In vitro evaluation of the activity of teriflunomide against SARS-CoV-2 and the human coronaviruses 229E and OC43.
- DOI
- 10.1016/j.bbrep.2022.101395
- Published
- 2023 Mar
- Container
- Biochemistry and biophysics reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbrep.2022.101395,
title = {In vitro evaluation of the activity of teriflunomide against SARS-CoV-2 and the human coronaviruses 229E and OC43.},
author = {Lang P and Geertsen SS and Lublin AL and Potter MC and Gladysheva T and Gregory JS and Rufi P},
year = {2023},
journal = {Biochemistry and biophysics reports},
doi = {10.1016/j.bbrep.2022.101395},
url = {https://doi.org/10.1016/j.bbrep.2022.101395}
}RIS
TY - JOUR TI - In vitro evaluation of the activity of teriflunomide against SARS-CoV-2 and the human coronaviruses 229E and OC43. AU - Lang P AU - Geertsen SS AU - Lublin AL AU - Potter MC AU - Gladysheva T AU - Gregory JS AU - Rufi P PY - 2023 JO - Biochemistry and biophysics reports DO - 10.1016/j.bbrep.2022.101395 UR - https://doi.org/10.1016/j.bbrep.2022.101395 ER -
APA
P, L., SS, G., AL, L., MC, P., T, G., JS, G., & P, R. (2023). In vitro evaluation of the activity of teriflunomide against SARS-CoV-2 and the human coronaviruses 229E and OC43.. Biochemistry and biophysics reports. https://doi.org/10.1016/j.bbrep.2022.101395
Source records
- pubmed · retrieved 2026-09-26T11:33:38.496Z